Lifecore Biomedical, Inc.
LFCR
$4.54
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 05/25/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 135.27M | 135.92M | 129.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 135.27M | 135.92M | 129.51M |
| Cost of Revenue | -- | -- | 92.57M | 91.15M | 87.15M |
| Gross Profit | -- | -- | 42.70M | 44.77M | 42.37M |
| SG&A Expenses | -- | -- | 38.68M | 38.13M | 41.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 139.29M | 137.34M | 136.95M |
| Operating Income | -- | -- | -4.02M | -1.42M | -7.44M |
| Income Before Tax | -- | -- | -32.08M | -25.25M | -31.84M |
| Income Tax Expenses | -- | -- | 401.00K | 421.50K | 63.50K |
| Earnings from Continuing Operations | -- | -- | -32.48 | -25.67 | -31.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -32.48M | -25.67M | -31.91M |
| EBIT | -- | -- | -4.02M | -1.42M | -7.44M |
| EBITDA | -- | -- | 4.00M | 6.60M | 590.00K |
| EPS Basic | -- | -- | -1.07 | -0.84 | -1.07 |
| Normalized Basic EPS | -- | -- | -0.47 | -0.43 | -0.55 |
| EPS Diluted | -- | -- | -1.07 | -0.84 | -1.08 |
| Normalized Diluted EPS | -- | -- | -0.47 | -0.43 | -0.55 |
| Average Basic Shares Outstanding | -- | -- | 145.79M | 145.79M | 139.24M |
| Average Diluted Shares Outstanding | -- | -- | 145.79M | 145.79M | 139.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |